Best for: Muscle injuries, multiple concurrent injuries, systemic inflammation Distribution: Whole-body via bloodstream Dosing frequency: Twice weekly during loading, once weekly maintenance Half-life: 24 to 48 hours Unique benefit: Reaches all injury sites from single injection Human Clinical Evidence Human clinical trials for Tb-500 remain remarkably sparse given its widespread underground use, but more data exists than for Bpc-157
One in eight women has to deal with this, and 12 % of the American population will experience this at some point in their lives
Short-term local injection site reactions, suchas pain, numbness, redness and swelling
Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available
You can, at this very moment, purchase many of the peptides on the restricted list online
[PMC free article] [PubMed] [Google Scholar] 8.Gwyer D, Wragg NM, Wilson SL: Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
